source
- Moderna delays norovirus vaccine readout, cites insufficient infectionsModerna announced that its norovirus vaccine trial will not yield efficacy data this season because infection rates were lower than expected. The company said it will open an additional trial coho…
- Biogen beats revenue expectations, lifts investor confidence with 3% sales riseBiogen reported $2.7 billion in revenue for the April‑June quarter, a 3% increase year over year, surpassing analysts' consensus estimate of $2.5 billion. Adjusted earnings per share came in at $3.…